Strides Pharma Science Ltd.

986.53.03%

2026-08-20

strides.comBSE: 532531NSE: STAR
Market Cap₹ 8,716 Cr.
Current Price₹ 958
High / Low₹ 1,231 / 769
Stock P/E14.2
Book Value₹ 355
Price to Book2.78
Dividend Yield0.53 %
ROCE18.6 %
ROE20.3 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2024 • Pharma: 100.0%

PROS

  • Promoters have been increasing their shareholding - up 2.1pp over 2 years
  • Latest quarter profit grew 56.7% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.49x)
  • Operating margins have improved to 11.9% from 8.3%
  • Company generates healthy free cash flow
  • Institutional investors have been accumulating - FII+DII up 2.5pp

CONS

  • A large part of profit comes from other income (34.6% of PBT)
  • Recurring exceptional / one-off items are inflating headline profit
  • Company has delivered a poor sales growth of 7.9% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1876.4037.22450211.210.852901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8600.0078.05228302.980.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.CIPLA1431.8534.32115672.460.91785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1117.0024.69111421.180.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2225.0018.40101734.760.811416.9816.018276.8934.2828.8629.59
7.MANKIND2390.0048.3298706.040.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1180.5030.5898533.480.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1814.4089.6698034.250.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1638.4525.3994272.790.241032.0325.229150.3517.4412.7620.54
11.BIOCON418.00137.5468121.210.12136.8053.364336.0010.893.2619.54
12.STAR945.6014.218715.850.53165.4956.731265.4113.0118.5718.06
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
930
763
Operating Profit
OPM %
Other Income
9
Interest
76
Depreciation
60
33
Tax %
29.11%
Net Profit
0
-1
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
999
846
Operating Profit
OPM %
Other Income
36
Interest
79
Depreciation
60
-115
Tax %
6.49%
Net Profit
0
-15
Equity Capital
90
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
90
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
1,006
864
Operating Profit
OPM %
Other Income
9
Interest
70
Depreciation
49
22
Tax %
73.19%
Net Profit
0
-1
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
1,044
839
Operating Profit
OPM %
Other Income
-14
Interest
71
Depreciation
48
64
Tax %
19.67%
Net Profit
0
3
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
1,054
864
Operating Profit
OPM %
Other Income
13
Interest
73
Depreciation
47
182
Tax %
10.45%
Net Profit
683
18
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
1,167
982
Operating Profit
OPM %
Other Income
28
Interest
74
Depreciation
48
87
Tax %
16.05%
Net Profit
94
8
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
1,154
943
Operating Profit
OPM %
Other Income
6
Interest
52
Depreciation
48
113
Tax %
21.09%
Net Profit
90
10
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
1,190
973
Operating Profit
OPM %
Other Income
12
Interest
50
Depreciation
49
103
Tax %
20.11%
Net Profit
86
9
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
1,120
902
Operating Profit
OPM %
Other Income
9
Interest
47
Depreciation
49
122
Tax %
13.49%
Net Profit
106
11
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
1,221
989
Operating Profit
OPM %
Other Income
27
Interest
46
Depreciation
50
154
Tax %
14.00%
Net Profit
132
14
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
1,195
959
Operating Profit
OPM %
Other Income
107
Interest
43
Depreciation
51
246
Tax %
15.21%
Net Profit
208
22
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
1,323
1,084
Operating Profit
OPM %
Other Income
8
Interest
42
Depreciation
53
147
Tax %
12.80%
Net Profit
129
14
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
1,265
1,133
Operating Profit
OPM %
Other Income
5
Interest
41
Depreciation
56
200
Tax %
17.09%
Net Profit
165
2
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
92
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
2,755
2,228
Operating Profit
688
OPM %
25
Other Income
161
Interest
183
Depreciation
126
343
Tax %
18
Net Profit
280
EPS
45
Dividend Payout %
10
Minority Interest
-46
Share of Associates
0
Adjusted EPS
45
Minority Interest
-46
Share of Associates
0
Adjusted EPS
45
Mar 2018
2,845
2,443
Operating Profit
491
OPM %
17
Other Income
88
Interest
196
Depreciation
154
80
Tax %
7
Net Profit
74
EPS
74
Dividend Payout %
3
Minority Interest
-20
Share of Associates
0
Adjusted EPS
74
Minority Interest
-20
Share of Associates
0
Adjusted EPS
74
Mar 2019
2,178
1,936
Operating Profit
283
OPM %
13
Other Income
41
Interest
79
Depreciation
117
62
Tax %
-43
Net Profit
89
EPS
36
Dividend Payout %
8
Minority Interest
-5
Share of Associates
0
Adjusted EPS
36
Minority Interest
-5
Share of Associates
0
Adjusted EPS
36
Mar 2020
2,752
2,236
Operating Profit
569
OPM %
21
Other Income
53
Interest
156
Depreciation
174
55
Tax %
21
Net Profit
43
EPS
4
Dividend Payout %
345
Minority Interest
6
Share of Associates
0
Adjusted EPS
4
Minority Interest
6
Share of Associates
0
Adjusted EPS
4
Mar 2021
3,316
2,689
Operating Profit
686
OPM %
21
Other Income
59
Interest
150
Depreciation
206
275
Tax %
11
Net Profit
244
EPS
30
Dividend Payout %
8
Minority Interest
11
Share of Associates
0
Adjusted EPS
30
Minority Interest
11
Share of Associates
0
Adjusted EPS
30
Mar 2022
3,070
3,092
Operating Profit
112
OPM %
4
Other Income
133
Interest
177
Depreciation
233
-653
Tax %
27
Net Profit
-474
EPS
-51
Dividend Payout %
0
Minority Interest
14
Share of Associates
0
Adjusted EPS
-51
Minority Interest
14
Share of Associates
0
Adjusted EPS
-51
Mar 2023
3,688
3,303
Operating Profit
521
OPM %
14
Other Income
135
Interest
261
Depreciation
243
-286
Tax %
19
Net Profit
-231
EPS
-22
Dividend Payout %
-7
Minority Interest
10
Share of Associates
0
Adjusted EPS
-22
Minority Interest
10
Share of Associates
0
Adjusted EPS
-22
Mar 2024
3,890
3,318
Operating Profit
622
OPM %
16
Other Income
50
Interest
280
Depreciation
214
-115
Tax %
-25
Net Profit
-144
EPS
-8
Dividend Payout %
-33
Minority Interest
24
Share of Associates
0
Adjusted EPS
-8
Minority Interest
24
Share of Associates
0
Adjusted EPS
-8
Mar 2025
4,565
3,768
Operating Profit
862
OPM %
19
Other Income
64
Interest
249
Depreciation
192
487
Tax %
16
Net Profit
409
EPS
390
Dividend Payout %
1
Minority Interest
-4
Share of Associates
0
Adjusted EPS
390
Minority Interest
-4
Share of Associates
0
Adjusted EPS
390
Mar 2026
4,859
4,014
Operating Profit
1,076
OPM %
22
Other Income
231
Interest
179
Depreciation
202
669
Tax %
14
Net Profit
575
EPS
60
Dividend Payout %
8
Minority Interest
-18
Share of Associates
0
Adjusted EPS
60
Minority Interest
-18
Share of Associates
0
Adjusted EPS
60
TTM
5,004
4,164
Operating Profit
OPM %
Other Income
147
Interest
172
Depreciation
210
746
Tax %
15
Net Profit
634
EPS
Dividend Payout %
Minority Interest
7
Share of Associates
-1
Adjusted EPS
Minority Interest
7
Share of Associates
-1
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
5%
5 Years:
8%
3 Years:
10%

COMPOUNDED PROFIT GROWTH

10 Years:
18%
5 Years:
16%
3 Years:

STOCK PRICE CAGR

10 Years:
5 Years:
3 Years:
1 Year:
10%

RETURN ON EQUITY

10 Years:
3%
5 Years:
1%
3 Years:
10%
Last Year:
20%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jul 31

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

2025

Jul 22

₹ 0.40

Rs.4.0000 per share(40%)Final Dividend

2024

Sep 9

₹ 0.25

Rs.2.5000 per share(25%)Final Dividend

2023

Aug 4

₹ 0.15

Rs.1.5000 per share(15%)Final Dividend

2021

Aug 5

₹ 0.25

Rs.2.5000 per share(25%)Final Dividend

2018

Sep 12

₹ 0.20

Rs.2.0000 per share(20%)Final Dividend

2017

Sep 7

₹ 0.45

Rs.4.5000 per share(45%)Dividend

2016

Jul 21

₹ 0.40

Rs.4.0000 per share(40%)Dividend

2026

Jul 21

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

Mar 2017
Equity Capital
89
2,651
2,062
Trade Payables
774
2,459
Total Liabilities
8,035
2,909
Capital Work in Progress
204
1,525
733
0
Cash & Bank
329
2,334
Total Assets
8,035
Total Debt
3,700
Net Working Capital
688
Contingent Liabilities
3,180
Book Value per Share
306.41
Face Value
10.00
Total Debt
3,700
Net Working Capital
688
Contingent Liabilities
3,180
Book Value per Share
306.41
Face Value
10.00
Mar 2018
Equity Capital
90
2,365
969
Trade Payables
712
2,450
Total Liabilities
6,585
2,903
Capital Work in Progress
322
588
552
0
Cash & Bank
303
1,917
Total Assets
6,585
Total Debt
2,520
Net Working Capital
550
Contingent Liabilities
3,248
Book Value per Share
274.26
Face Value
10.00
Total Debt
2,520
Net Working Capital
550
Contingent Liabilities
3,248
Book Value per Share
274.26
Face Value
10.00
Mar 2019
Equity Capital
90
2,552
1,413
Trade Payables
889
2,864
Total Liabilities
7,807
3,570
Capital Work in Progress
100
702
874
0
Cash & Bank
517
2,045
Total Assets
7,807
Total Debt
3,219
Net Working Capital
386
Contingent Liabilities
3,316
Book Value per Share
294.94
Face Value
10.00
Total Debt
3,219
Net Working Capital
386
Contingent Liabilities
3,316
Book Value per Share
294.94
Face Value
10.00
Mar 2020
Equity Capital
90
2,432
1,358
Trade Payables
798
1,276
Total Liabilities
5,953
2,026
Capital Work in Progress
148
549
783
0
Cash & Bank
237
2,210
Total Assets
5,953
Total Debt
1,962
Net Working Capital
-174
Contingent Liabilities
2,379
Book Value per Share
281.55
Face Value
10.00
Total Debt
1,962
Net Working Capital
-174
Contingent Liabilities
2,379
Book Value per Share
281.55
Face Value
10.00
Mar 2021
Equity Capital
90
2,682
1,221
Trade Payables
1,134
1,690
Total Liabilities
6,817
2,151
Capital Work in Progress
228
697
1,201
0
Cash & Bank
180
2,360
Total Assets
6,817
Total Debt
2,103
Net Working Capital
79
Contingent Liabilities
844
Book Value per Share
309.09
Face Value
10.00
Total Debt
2,103
Net Working Capital
79
Contingent Liabilities
844
Book Value per Share
309.09
Face Value
10.00
Mar 2022
Equity Capital
90
2,267
1,953
Trade Payables
1,072
1,380
Total Liabilities
6,761
2,333
Capital Work in Progress
56
540
1,174
0
Cash & Bank
187
2,470
Total Assets
6,761
Total Debt
2,792
Net Working Capital
-50
Contingent Liabilities
834
Book Value per Share
262.48
Face Value
10.00
Total Debt
2,792
Net Working Capital
-50
Contingent Liabilities
834
Book Value per Share
262.48
Face Value
10.00
Mar 2023
Equity Capital
90
2,103
1,632
Trade Payables
982
1,567
Total Liabilities
6,373
2,298
Capital Work in Progress
48
490
1,147
0
Cash & Bank
316
2,074
Total Assets
6,373
Total Debt
2,774
Net Working Capital
145
Contingent Liabilities
632
Book Value per Share
242.83
Face Value
10.00
Total Debt
2,774
Net Working Capital
145
Contingent Liabilities
632
Book Value per Share
242.83
Face Value
10.00
Mar 2024
Equity Capital
92
2,031
1,624
Trade Payables
852
975
Total Liabilities
5,572
1,853
Capital Work in Progress
80
303
1,126
1,142
Cash & Bank
191
877
Total Assets
5,572
Total Debt
2,415
Net Working Capital
90
Contingent Liabilities
475
Book Value per Share
230.95
Face Value
10.00
Total Debt
2,415
Net Working Capital
90
Contingent Liabilities
475
Book Value per Share
230.95
Face Value
10.00
Mar 2025
Equity Capital
92
2,459
1,136
Trade Payables
1,032
1,059
Total Liabilities
5,780
1,888
Capital Work in Progress
100
409
1,278
1,203
Cash & Bank
137
765
Total Assets
5,780
Total Debt
1,796
Net Working Capital
507
Contingent Liabilities
98
Book Value per Share
276.83
Face Value
10.00
Total Debt
1,796
Net Working Capital
507
Contingent Liabilities
98
Book Value per Share
276.83
Face Value
10.00
Mar 2026
Equity Capital
92
3,015
1,039
Trade Payables
1,310
1,187
Total Liabilities
6,643
2,100
Capital Work in Progress
161
291
1,635
1,289
Cash & Bank
213
954
Total Assets
6,643
Total Debt
1,669
Net Working Capital
717
Contingent Liabilities
119
Book Value per Share
337.08
Face Value
10.00
Total Debt
1,669
Net Working Capital
717
Contingent Liabilities
119
Book Value per Share
337.08
Face Value
10.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
288
Cash from Investing
-687
Cash from Financing
338
-60
Free Cash Flow
2
OCF / Net Profit
1.03
Cumulative 5-Year FCF
0
OCF / Net Profit
1.03
Cumulative 5-Year FCF
0
Mar 2018
187
Cash from Investing
583
Cash from Financing
-1,016
-246
Free Cash Flow
27
OCF / Net Profit
2.52
Cumulative 5-Year FCF
0
OCF / Net Profit
2.52
Cumulative 5-Year FCF
0
Mar 2019
60
Cash from Investing
-148
Cash from Financing
194
106
Free Cash Flow
-537
OCF / Net Profit
0.67
Cumulative 5-Year FCF
0
OCF / Net Profit
0.67
Cumulative 5-Year FCF
0
Mar 2020
205
Cash from Investing
1,306
Cash from Financing
-1,709
-199
Free Cash Flow
205
OCF / Net Profit
4.72
Cumulative 5-Year FCF
0
OCF / Net Profit
4.72
Cumulative 5-Year FCF
0
Mar 2021
481
Cash from Investing
-521
Cash from Financing
-16
-55
Free Cash Flow
95
OCF / Net Profit
1.97
Cumulative 5-Year FCF
-209
OCF / Net Profit
1.97
Cumulative 5-Year FCF
-209
Mar 2022
-258
Cash from Investing
-119
Cash from Financing
421
45
Free Cash Flow
-477
OCF / Net Profit
0.54
Cumulative 5-Year FCF
-688
OCF / Net Profit
0.54
Cumulative 5-Year FCF
-688
Mar 2023
44
Cash from Investing
302
Cash from Financing
-214
133
Free Cash Flow
-41
OCF / Net Profit
-0.19
Cumulative 5-Year FCF
-755
OCF / Net Profit
-0.19
Cumulative 5-Year FCF
-755
Mar 2024
701
Cash from Investing
-150
Cash from Financing
-693
-143
Free Cash Flow
701
OCF / Net Profit
-4.87
Cumulative 5-Year FCF
483
OCF / Net Profit
-4.87
Cumulative 5-Year FCF
483
Mar 2025
684
Cash from Investing
-90
Cash from Financing
-643
-48
Free Cash Flow
641
OCF / Net Profit
1.67
Cumulative 5-Year FCF
919
OCF / Net Profit
1.67
Cumulative 5-Year FCF
919
Mar 2026
703
Cash from Investing
-173
Cash from Financing
-453
76
Free Cash Flow
235
OCF / Net Profit
1.22
Cumulative 5-Year FCF
1,059
OCF / Net Profit
1.22
Cumulative 5-Year FCF
1,059

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
EPS (₹)
44.70
Book Value (₹)
306.41
Dividend per Share (₹)
4.50
Cash EPS (₹)
45.39
Operating Margin %
24.98%
Net Margin %
10.15%
ROE %
10.37%
ROCE %
8.32%
3.63%
Debtor Days
134
Inventory Days
89
Payable Days
221
3
Debt to Equity (x)
1.35x
Interest Coverage (x)
2.87x
1.22x
Revenue Growth %
-3.73%
Operating Profit Growth %
36.03%
Net Profit Growth %
136.75%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
74.25
Book Value (₹)
274.26
Dividend per Share (₹)
2.00
Cash EPS (₹)
25.51
Operating Margin %
17.24%
Net Margin %
2.61%
ROE %
2.86%
ROCE %
4.83%
1.02%
Debtor Days
120
Inventory Days
82
Payable Days
197
6
Debt to Equity (x)
1.03x
Interest Coverage (x)
1.41x
1.29x
Revenue Growth %
3.25%
Operating Profit Growth %
-28.74%
Net Profit Growth %
-73.45%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
36.25
Book Value (₹)
294.94
Dividend per Share (₹)
3.00
Cash EPS (₹)
23.08
Operating Margin %
8.48%
Net Margin %
2.67%
ROE %
3.50%
ROCE %
2.61%
1.24%
Debtor Days
102
Inventory Days
78
Payable Days
269
-89
Debt to Equity (x)
1.22x
Interest Coverage (x)
1.79x
1.15x
Revenue Growth %
-23.43%
Operating Profit Growth %
-42.28%
Net Profit Growth %
20.19%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
4.06
Book Value (₹)
281.55
Dividend per Share (₹)
14.00
Cash EPS (₹)
24.23
Operating Margin %
12.08%
Net Margin %
0.92%
ROE %
1.68%
ROCE %
4.06%
0.63%
Debtor Days
74
Inventory Days
64
Payable Days
274
-136
Debt to Equity (x)
0.78x
Interest Coverage (x)
1.35x
0.93x
Revenue Growth %
26.33%
Operating Profit Growth %
100.96%
Net Profit Growth %
-51.42%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
29.93
Book Value (₹)
309.09
Dividend per Share (₹)
2.50
Cash EPS (₹)
50.19
Operating Margin %
12.54%
Net Margin %
4.45%
ROE %
9.21%
ROCE %
9.08%
3.82%
Debtor Days
68
Inventory Days
66
Payable Days
265
-130
Debt to Equity (x)
0.76x
Interest Coverage (x)
2.84x
1.03x
Revenue Growth %
20.49%
Operating Profit Growth %
20.61%
Net Profit Growth %
462.28%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
-51.25
Book Value (₹)
262.48
Dividend per Share (₹)
0.00
Cash EPS (₹)
-26.87
Operating Margin %
2.10%
Net Margin %
-8.90%
ROE %
-18.49%
ROCE %
-9.49%
-6.99%
Debtor Days
79
Inventory Days
81
Payable Days
268
-107
Debt to Equity (x)
1.18x
Interest Coverage (x)
-2.69x
0.99x
Revenue Growth %
-7.41%
Operating Profit Growth %
-83.70%
Net Profit Growth %
-294.53%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
-22.44
Book Value (₹)
242.83
Dividend per Share (₹)
1.50
Cash EPS (₹)
1.37
Operating Margin %
8.33%
Net Margin %
-3.70%
ROE %
-10.15%
ROCE %
-0.49%
-3.52%
Debtor Days
73
Inventory Days
68
Payable Days
230
-89
Debt to Equity (x)
1.27x
Interest Coverage (x)
-0.10x
1.05x
Revenue Growth %
20.13%
Operating Profit Growth %
365.23%
Net Profit Growth %
51.31%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
-7.68
Book Value (₹)
230.95
Dividend per Share (₹)
2.50
Cash EPS (₹)
7.59
Operating Margin %
9.40%
Net Margin %
-2.36%
ROE %
-6.67%
ROCE %
3.47%
-2.41%
Debtor Days
73
Inventory Days
68
Payable Days
191
-50
Debt to Equity (x)
1.14x
Interest Coverage (x)
0.59x
1.03x
Revenue Growth %
5.47%
Operating Profit Growth %
19.51%
Net Profit Growth %
37.68%
65.76%
P/E (x)
0.00x
P/B (x)
3.39x
Dividend Yield %
0.32%
15.14x
Mar 2025
EPS (₹)
389.90
Book Value (₹)
276.83
Dividend per Share (₹)
4.00
Cash EPS (₹)
65.28
Operating Margin %
11.25%
Net Margin %
5.77%
ROE %
17.52%
ROCE %
16.56%
7.21%
Debtor Days
60
Inventory Days
62
Payable Days
174
-51
Debt to Equity (x)
0.70x
Interest Coverage (x)
2.96x
1.20x
Revenue Growth %
17.36%
Operating Profit Growth %
38.49%
Net Profit Growth %
384.50%
5174.47%
P/E (x)
1.72x
P/B (x)
2.42x
Dividend Yield %
0.60%
9.08x
Mar 2026
EPS (₹)
60.34
Book Value (₹)
337.08
Dividend per Share (₹)
5.00
Cash EPS (₹)
84.29
Operating Margin %
11.95%
Net Margin %
8.13%
ROE %
20.31%
ROCE %
18.57%
9.25%
Debtor Days
64
Inventory Days
75
Payable Days
218
-79
Debt to Equity (x)
0.54x
Interest Coverage (x)
4.75x
1.25x
Revenue Growth %
6.43%
Operating Profit Growth %
24.89%
Net Profit Growth %
40.33%
-84.52%
P/E (x)
15.54x
P/B (x)
2.78x
Dividend Yield %
0.53%
9.39x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
25.86
26.71
18.17
0.01
28.87
Sep 2024
25.84
30.08
18.24
0.01
25.83
Dec 2024
26.82
28.48
16.92
0.01
27.77
Mar 2025
28.30
28.32
13.72
0.01
29.65
Jun 2025
28.30
28.02
13.30
0.01
30.37
Sep 2025
27.86
28.51
12.98
0.01
30.64
Dec 2025
27.86
29.52
13.02
0.01
29.59
Mar 2026
27.91
28.68
14.44
0.01
28.95
Jun 2026
27.91
28.40
15.42
0.01
28.28

Documents

Announcements

  • Press Release

    2026-08-19 - Strides Pharma Science Limited has informed the Exchange regarding a press release dated August 19, 2026, titled "Strides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru".

  • Shareholders meeting

    2026-08-18 - Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 14, 2026. Further, the company has informed the Exchange regarding voting results.

Credit Ratings

Nothing filed yet.

Concalls